Challenges to the Paclitaxel/Carboplatin Algorithm in Ovarian Cancer Treatment

被引：0
|
作者：
Zorn, Kristin K. [1 ]
机构：
[1] UPMC, Magee Womens Hosp, Gynecol Canc Program, Pittsburgh, PA USA
来源：
ONCOLOGY-NEW YORK | 2010年 / 24卷 / 08期
关键词：
GYNECOLOGIC-ONCOLOGY-GROUP; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; CARCINOMA; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：738 / 740
页数：2
相关论文
共 50 条
  • [1] Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer Points
    Boyd, Leslie R.
    Muggia, Franco M.
    ONCOLOGY-NEW YORK, 2018, 32 (08): : 418 - 424
  • [2] Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer
    De Placido, S
    Tramontana, S
    Ferrari, E
    De Matteis, A
    Lauria, R
    Perrone, F
    Bianco, AR
    Gallo, C
    Ricchi, P
    De Placido, G
    Pignata, S
    ANTICANCER RESEARCH, 2000, 20 (5C) : 4023 - 4029
  • [3] Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with advanced ovarian cancer
    Yoshida, H.
    Sumi, T.
    Abe, K.
    Ishiko, O.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 30 (05) : 583 - 585
  • [4] First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients
    Romanini, A
    Tanganelli, L
    Carnino, F
    Fanucchi, A
    Lionetto, R
    Pastorino, S
    Cosio, S
    Gadducci, A
    Conte, PF
    GYNECOLOGIC ONCOLOGY, 2003, 89 (03) : 354 - 359
  • [5] Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
    Blank, Stephanie V.
    Christos, Paul
    Curtin, John P.
    Goldman, Noah
    Runowicz, Carolyn D.
    Sparano, Joseph A.
    Liebes, Leonard
    Chen, Helen X.
    Muggia, Franco M.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (03) : 451 - 456
  • [6] The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer
    Hoekstra, Anna V.
    Hurteau, Jean A.
    Kirschner, Carolyn V.
    Rodriguez, Gustavo C.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (03) : 377 - 381
  • [7] CARBOPLATIN AND PACLITAXEL (TAXOL(R)) FOR THE TREATMENT OF ADVANCED OVARIAN-CANCER
    OZOLS, RF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 : 13 - 17
  • [8] Comparison of Efficacies of Dose Dense Paclitaxel Plus Carboplatin and Conventional Paclitaxel Plus Carboplatin in the Treatment of Epithelial Ovarian Cancer
    Sunar, Veli
    Korkmaz, Vakkas
    Aslan, Koray
    Kose, Caner
    Sarici, Furkan
    Arik, Zafer
    Meydanli, Mehmet Mutlu
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (04): : 239 - 245
  • [9] Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: a report of 7 cases and a review of the literature
    Mabuchi, Seiji
    Morishige, Kenichirou
    Enomoto, Takayuki
    Kimura, Tadashi
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2010, 21 (02) : 93 - 96
  • [10] A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer
    Aghajanian, Carol
    Filiaci, Virginia
    Dizon, Don S.
    Carlson, Jay W.
    Powell, Matthew A.
    Secord, Angeles Alvarez
    Tewari, Krishnansu S.
    Bender, David P.
    O'Malley, David M.
    Stuckey, Ashley
    Gao, Jianjiong
    Dao, Fanny
    Soslow, Robert A.
    Lankes, Heather A.
    Moore, Kathleen
    Levine, Douglas A.
    GYNECOLOGIC ONCOLOGY, 2018, 150 (02) : 274 - 281
12345